Advisory Committee on Heritable Disorders in Newborns and Children Upcoming Meeting February 10-11 | Webinar Participant Information* indicates a required fieldFirst Name*Last Name*SuffixOrganization*TitleEmail* Enter Email Confirm Email Please provide your state/province and country* State / Province / Region CountryAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongo, Democratic Republic of theCongo, Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatini (Swaziland)EthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth GeorgiaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaVietnamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Registration Category*Select one...Committee MemberOrganizational Representative for the ACHDNCLaboratory Standards and Procedures WorkgroupFollow-Up and Treatment WorkgroupEducation and Training WorkgroupSpeakerHHS EmployeeHRSA GranteeState Public Health DepartmentPressParent/Consumer/AdvocateOtherPlease note that "Organizational Representative" has specific role for this Committee. If you are attending on behalf of your organization, please select Other.Other - Please Specify*Special NeedsPlease note that there are two public comment periods. Comments for Mucopolysaccharidosis type II (MPS II) will be on Thursday, Feb. 10. General comments on other topics will be given on Feb. 11. Presentations of comments may be limited depending on the number of presenters. Individuals who are associated with groups having similar interests are requested to combine their comments and present them through a single representative. No audiovisual presentations are permitted. HRSA will contact you via email to provide specific instructions on presenting oral comments.Public CommentsI would like to submit written public comments.I would like to provide oral public comments during the meeting.No, I would not like to submit public commentsWill you be providing a public comment for MPS II or during the general public comment?MPS IIGeneralBothWhat topic(s) will you address in your oral public comments?*Are you submitting public comments:*As an individualWith othersPlease specify the other people:*Enter 1 name per linePlease attach the document(s) (MS Word or PDF Format) with your written comment(s).* Drop files here or Accepted file types: pdf, doc, docx. 10mb max file sizeAlthough not required, you may submit a written version of your public comment. Drop files here or Accepted file types: pdf, doc, docx. 10mb max file sizeNameThis field is for validation purposes and should be left unchanged.
